Praxis Precision Medicines, Inc.·4

Jan 13, 7:45 AM ET

Sweeny Nicole 4

4 · Praxis Precision Medicines, Inc. · Filed Jan 13, 2023

Insider Transaction Report

Form 4
Period: 2023-01-12
Sweeny Nicole
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-12+41,08541,085 total
    Exercise: $2.96From: 2023-01-12Exp: 2033-01-12Common Stock (41,085 underlying)
Footnotes (1)
  • [F1]Ms. Sweeny opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022.

Documents

1 file
  • 4
    wf-form4_167361390389054.xmlPrimary

    FORM 4